Arquivo de Terminado

7th BrEaST Cancer Weekend

By admin1990Terminado

7^th BrEaST Cancer Weekend

A Clínica de Mama do IPO Porto tem muito gosto em anunciar a 7ª Reunião “O melhor do tratamento do cancro da mama em 2024”, a 7 e 8 de fevereiro 2025 no Auditório Principal do IPO Porto.

EspecialistasMÉDICOS

€ 85,00

Inclui:

Acesso às Palestras
Pasta c/ Documentação
Almoço
Coffee Break
Certificado de Presença

InternosMÉDICOS

€ 40,00

Inclui:

Acesso às Palestras
Pasta c/ Documentação
Almoço
Coffee Break
Certificado de Presença

EstudantesESTUDANTES

€ 20,00

Inclui:

Acesso às Palestras
Pasta c/ Documentação
Almoço
Coffee Break
Certificado de Presença

Inscrições limitadas às vagas existentes
Inscrições disponíveis até 31 de janeiro 2025

Programa Científico

7^th February 2025 7 de fevereiro 2025

09:00h

Opening Session
Sessão Abertura
Júlio Oliveira; Donzília Brito; Deolinda Pereira; J. Abreu de Sousa; José Dinis; Olga Sousa; Susana Dias

09:15h	Breast cancer screening: New challenges Rastreio do cancro da mama: Novos desafios João Paulo Souto; Gabriela Sousa; Fernando Tavares; Fernando Castro
09:20h	What public health says? \| Mariana Carrapatoso O que a saúde pública diz?
09:35h	Work for imaging? \| Ana Paula Vasconcelos Trabalho para imagiologia?
09:50h	Concerns to surgeons? \| Paulina Lopes Preocupações para os cirurgiões?
10:05h	Reach patients? \| LPC Aproximação aos doentes?
10:20h	Discussion \| Discussão

10:35h

Coffee Break

11:00h	DCIS and small tumors DCIS e pequenos tumores Teresa Santos; Sofia Braga; Isabel Azevedo; Cláudia Carneiro Bilber
11:05h	Radiotherapy: Novel scenarios \| Ferran Guedea Radioterapia: Novos cenários
11:20h	Not only imaging but also treating \| J. Maria Oliver-Goldaracena Não apenas imagiologia, mas também tratamento
11:35h	Data for no use of operating room \| Teresa Dias Dados para não utilização do bloco operatório
11:50h	How to face systemic treatment \| Iolanda Mendes Como encarar o tratamento sistémico
12:05h	Discussion \| Discussão

12:20h	Early breast cancer Cancro da Mama Precoce J. Luís Passos Coelho; Joana Loureiro; Fernando Martins; André Laranja
12:25h	Treating and knowing axilla. More controversies for 2025 Tratando e conhecendo a axila. Mais polémicas para 2025
12:25h	Ready to move on \| Cátia Ribeiro Pronto para seguir em frente
12:35h	Walk with caution \| Rodrigo Oom Avançar com precaução
12:45h	When axilla is a concern even for oncologists \| Nuno Tavares Quando a axila é preocupação até para oncologistas
13:00h	More aggressive treatment in high risk early breast cancer. Focus on elderly \| Alexandra Teixeira Tratamento mais agressivo no cancro da mama precoce de alto risco. Foco nos idosos
13:15h	Discussion \| Discussão

13:30h

Lunch / Almoço

14:40h

Conference / Conferência
Genetics and breast cancer. Not only risk. Not only treatment | Teresa Curiel
Genética e cancro de mama. Não apenas risco. Não apenas tratamento
Fátima Vaz; Ida Negreiros; Manuel Teixeira; Vanda Patrício; Miguel Abreu

15:40h	Facing new drugs in brain metastasis HER2+ BC. Can we spare local treatment? Novas drogas no tratamento da doença cerebral HER2+. Podemos poupar o tratamento local? António Verdelho; João Macário Conde; Mónica Mariano
15:45h	Neurosurgery \| Bruno Carvalho Neurocirurgia
16:00h	Radiotherapy \| Ana Luísa Vasconcelos Radioterapia
16:15h	Oncology \| Cláudia Caeiro Oncologia
17:20h	Discussion \| Discussão

16:45h	Advanced breast cancer Cancro da mama avançado Susana Sousa; Marta Sousa
16:50h	Decision making with new and not so new drugs in HER 2+ BC \| Berta Sousa Tomada de decisão com medicamentos novos e não tão novos no cancro da mama HER 2+
17:10h	Novel scenarios in HR+ HER2- breast cancer \| Paolo Tarantino Novos cenários cancro da mama HR+ HER2–
17:30h	Discussion \| Discussão

8^th February 2025 8 de fevereiro 2025

09:15h	Let's talk about: Young patients and breast cancer. Old problems increasing? Vamos falar sobre: Pacientes jovens e cancro da mama. Um problema antigo que tem vindo a aumentar?
	Facts \| Teresa Mota Garcia Factos Talk \| Luís Costa; Ana Ferreira; Cristina Oliveira; Sónia Castro

09:45h	Immunotherapy and breast cancer Imunoterapia e cancro da mama Paulo Cortes; Marta Ferreira; Rita Sousa; Nuno Coimbra
09:50h	Immuno biomarkers and immunotherapy \| Isabel Pimentel Biomarcadores imunológicos e imunoterapia
10:05h	Early relapse post neo and adjuvant treatment \| Joana M. Ribeiro Recaída precoce após tratamento neo e adjuvante
10:25h	From negative breast cancer to positive breast cancer \| Paola Zagami De cancro da mama negativo para cancro da mama positivo
10:45h	Discussion \| Discussão

11:00h

Coffee Break

11:30h	Breast cancer on the desk O cancro da mama em cima da secretária J. Abreu de Sousa, Miguel Barbosa; Carlos Alves
11:35h	New drugs: New and old problems \| Julian Perelman Novas drogas: Novos e velhos problemas
11:55h	New healthcare management \| Xavier Barreto Nova gestão em saúde
	Local health unit Unidade Local de Saúde (ULS)
	Integrated Responsibility Centers Centros de Responsabilidade Integrados (CRI)
12:15h	Discussion \| Discussão

12:30h	Issues in inequality Questões de desigualdade Mónica Nave, Fernando Osório, Sandra Sousa
12:35h	Medical issues \| Joana Mendonça Questões médicas
12:45h	Psycological issues \| Susana Almeida Questões psicológicas
12:55h	Social and legal issues \| Andreia da Costa Andrade Questões sociais e jurídicas
13:05h	Discussion \| Discussão

13:20h

Closing Session
Sessão Encerramento

1^st Theoretical-practical Satellite Course in Breast Imaging and Intervention, IPO-Porto

1º Curso Satélite teórico-prático em Imagiologia e Intervenção de Mama IPO-Porto

Público Alvo

Médicos internos em formação específica em Imagiologia e Médicos especialistas em Imagiologia Mamária

Curso Teórico

Nº de Participantes

60

Duração

175 min

Localização

Auditório Azul

Workshop prático de procedimentos Intervenção de Mama

Nº de Participantes

20

Duração

45 min

Localização

Serviço de Radiologia
Sector de Imagiologia Mamária

Programa Científico

7^th February 2025 7 de fevereiro 2025

14:20h

Opening Session
Sessão Abertura
Cláudia Carneiro Bilber - IPO Porto

14:30h

How not to overuse Birads 3? How to manage Birads 0?
Como não abusar do Birads 3? Como orientar Birads 0?
Willian Schmitt - ULS Trás-os-Montes e Alto Douro

14:50h

Contrast Mammography: Technique, Advantages and Limitations
Mamografia de contraste: técnica, vantagens e limitações
Miguel Braga - IPO Lisboa

15:10h

Axillary evaluation: what does the clinician need to know?
Avaliação axilar: o que o clínico precisa saber?
Ana Sofia Preto - ULS S. João

15:30h

Microbiopsy vs VAB: How and When?
Microbiópsia vs BAV: como e quando?
Manuela Certo - ULS Braga

15:50h

Breast lesions localisation: devices and their indications
Localização de lesões mamárias: dispositivos e suas indicações
João Amorim - IPO Porto

16:10h

CEM-guided VAB: the new kid on the block!
BAV guiada por mamografia de contraste: a novidade na área!
Cláudia Carneiro Bilber - IPO Porto

16:30h

Clinic Cases IPO Porto
Casos Clínicos IPO Porto
João Amorim, Joana Abreu e Silva, Beatriz Freixo, Gonçalo Rebelo – IPO Porto

17:15h

Coffee Break

17:45h

Practical workshop on Breast Intervention procedures (20 participants)
Workshop prático de procedimentos Intervenção de Mama (20 participantes)
João Amorim, Cláudia Carneiro Bilber, Ana Galiza, Beatriz Freixo, Gonçalo Rebelo, Fátima Gomes, Teresa Castro, Elisabete Sousa, Ana Luísa Silva - IPO Porto

18:30h

Closing Session
Sessão de Encerramento

Regras para Submissão de Trabalhos Científicos

Os trabalhos científicos deverão corresponder ao âmbito da temática do Breast Cancer Weekend.

01. Estrutura

Deverá ser utilizado o template word que se encontra no final desta página. Por favor faça download e preencha respeitando a estrutura e exemplos do mesmo:

Título do trabalho;
Nome, apelido, local de trabalho dos autores e email;
Escolha da temática pretendida com a seguinte estrutura:

Trabalhos Clínicos – Introdução, Descrição, Discussão e Conclusão.
Ciências Básicas – Introdução, Descrição, Discussão e Conclusão.

O conteúdo do resumo não deverá ter a identificação de nenhum dos autores ou fazer alusão a qualquer outro dado que possa comprometer o anonimato. Poderá conter até um máximo de 2500 caracteres, incluídos espaços, respeitando o acordo ortográfico em vigor.

02. Candidatura

Os resumos dos trabalhos científicos deverão ser enviados até ao dia 31 de janeiro 2025 em formato PDF para: eventos@lab52.pt.
Serão notificados todos os autores até ao dia 03 de fevereiro 2025 sobre a aceitação do trabalho.
Pelo menos um dos autores terá que estar inscrito no congresso.

03. Formato

Todos os trabalhos aceites serão apresentados em forma de e-poster.
Será disponibilizado template Powerpoint para a sua realização. Este template já se encontrará dimensionado corretamente para o bom funcionamento e visualização. A organização não se responsabiliza pelo não funcionamento ou falta de qualidade dos e-posters elaborados noutros programas ou formatos.
Os trabalhos serão exibidos num ecrã no dia do evento. Deverão ser enviados em formato JPG até às 23:59 do dia 05 de fevereiro 2025, para eventos@lab52.pt.

04. Prémios

Serão atribuídos o 1º e 2º prémio aos melhores trabalhos científicos de cada área temática. A divulgação dos vencedores será feita na sessão de encerramento no dia 08 fevereiro 2025. Pelo menos um dos autores deverá estar presente na sessão sob pena de não receber o prémio atribuído.

Temática	1º Prémio	2º Prémio
Trabalhos Clínicos	600,00 €	300,00 €
Ciências Básicas	600,00 €	300,00 €

Abstract Template

Organização

Apoio

Científicos

Indústria

IPO Porto

Instituto Português de Oncologia do Porto FG, EPE

O IPO-Porto tem como missão a prestação de cuidados de saúde, em tempo útil, centrados no doente, não descurando a prevenção, a investigação, a formação e o ensino no domínio da oncologia com o objetivo de garantir elevados níveis de qualidade, humanismo e eficiência.

R. Dr. António Bernardino de Almeida 865,
4200-072 Porto, Portugal

(+351) 225 084 000

www.ipoporto.pt

Ligia Silva

(+351) 914 592 380

Email

eventos@lab52.pt

Email

geral@lab52.pt

Inscrições ENCERRADAS!

Obrigado

31 Dezembro, 2024

Love0

GRELL

By admin1990Terminado

GRELL & ENCR

Ascension Meeting 2025

The 49^th GRELL Annual Meeting will take place in Porto, Portugal, from 27^th to 30^th May 2025.

The GRELL 2025 meeting will be particularly special, as it will also host the ENCR (European Network of Cancer Registries) meeting. In this context, workshops will be organized on Tuesday, followed by a 3-day GRELL-ENCR conference.

Stay tuned! Further information will follow soon.

The institution hosting the event

Instituto Português de Oncologia do Porto FG, EPE

IPO Porto mission is to provide timely, patient-centered healthcare, without neglecting prevention, research, training and teaching in the field of oncology with the aim of ensuring high levels of quality, humanism and efficiency.

EUROSTARS OPORTO

Modern, functional and well connected: a reference hotel in Porto

The Eurostars Oporto Hotel is a modern, newly-built hotel boasting an optimal, strategic location very near the main entrances to the city and just 15 minutes from the airport. The Hospital São João, the most important universities and the Das Antas zone, the home to Oporto’s Do Dragão football stadium, are all just a few minutes away from the Oporto hotel. The modern, attractive building houses a highly functional hotel in Oporto with 64 apartments, ideal for longer stays, along with 6 meeting rooms, a restaurant, bar, television room, business centre and two parking zones (one indoor and one outdoor). Because of its location, features and comfort, it is a great option for both business and pleasure travel. The Eurostars Oporto Hotel is also perfectly equipped for hosting all kinds of events from working meetings to conventions or banquets thanks to its numerous meeting rooms and their functionality.

CONTACTS

Rua do Mestre Guilherme Camarinha, 212
4200-537, Porto
Portugal

350 meters on foot – 5 min
2,3 km by car – 5 min

Reservation: Eurostars Hotels
Promocode: GRELL25

Axis Porto & Spa Hotel

The Hotel in Porto, ideal for a leisure or business stay

This Hotel in Porto is the ideal place for those who opt for a comfortable stay, close to the most important tourist attractions in the city, whether for leisure or business reasons. Combine rest or work with the discovery of a stunning city or relax at Axis Porto Hotel, which allows you to “forget” stress and take the opportunity to promote your physical and mental well-being.

The Hotel’s SPA offers, in a sophisticated and elegant environment, treatments designed to enhance diversified experiences, in addition to the 3 massage rooms, it also has a dynamic pool, Sauna, Turkish bath and sensory shower.

CONTACTS

Rua Maria Feliciana, 100
4465-283, São Mamede de Infesta – Porto
Portugal

1,4 km on foot – 20 min
1,4 km by car – 4 min

Reservation: Axis Hotéis & Golfe
Promocode: GRELL25

ibis Porto São João

Vibrant economy hotel, open to everyone

The ibis Porto Sao Joao hotel is located in Porto University district, close to Sao Joao hospital and on the top floor of the Campus Sao Joao shopping center. The hotel is strictly non-smoking, and features 4 fully equipped meeting rooms plus fast and direct access to the city old town via the metro station next to the hotel and to the Exponor and Europarque business centers. Relax in one of our 100 comfortable rooms and enjoy the 24-hour bar and snack service, free outdoor parking and free WIFI.

The ibis Porto São João has many advantages for those who visit Porto because it is located in the city’s university complex and provides quick access to the Exponor and Europarque business centers. At ibis Porto São João, Porto city center is 10 minutes away by car or metro. The metro station next to the hotel takes you straight to the historic center. Leave the car and stress behind, for free.

CONTACTS

Rua Dr Placido Costa,
4200-450 Porto
Portugal

(+351) 225 513 100
h3227@accor.com
www.all.accor.com

500 meters on foot – 7 min
850 meters by car – 3 min

Provisional Scientific Program

Preliminary program — timing may be adjusted

	Tuesday, May 27^th
08:30 - 10:00	Registration
	Workshop 1 ICD-O-4: towards application in population-based cancer registries
10:00 - 11:00	Session 1 - ICD-O-4 Developments Welcoming words Co-moderators: Laura Ortelli GRELL SC representative Switzerland & Maciej Trojanowski ENCR SC representative Poland Keynote speaker 1 ICD-O-4: development - Introduction and background, planned timelines, planned support/tools for the registries Ariana Znaor International Agency for Research on Cancer (IARC), France Keynote speaker 2 ICD-O-4: Changes compared to previous editions Brian Rous Cambridge University Hospital, UK Q&A
11:00 - 11:30	Coffee Break
11:30 - 12:30	Session 2 - Perspectives from PBCRs Co-moderators: Laura Ortelli GRELL SC representative Switzerland & Maciej Trojanowski ENCR SC representative Poland Keynote speaker 3 Plans for ICD-O-4 implementation at the Irish Cancer Registry Deirdre Murray ENCR SC representative, Ireland Keynote speaker 4 Implications for coding and research at the cancer registry Rafael Marcos-Gragera Girona Cancer Registry, Spain Interactive Quiz Q&A
12:30 - 13:45	Lunch Break
	Workshop 2 Is your data available for this year? Strategies to enhance timeliness at population-based cancer registries
13:45 - 14:45	Session 1 - TBD Introduction Co-moderators: Claudine Backes GRELL SC representative Luxembourg and ENCR SC representative Luxembourg & Valérie Jooste GRELL SC representative France Keynote speaker 1 Is your data available for this year? Practical aspects and techniques for addressing timeliness at the cancer registry Freddie Bray International Agency for Research on Cancer (IARC), France Q&A
14:45 - 15:45	Session 2 - Registry Practice Co-moderators: Valérie Jooste GRELL SC representative France & Freddie Bray IARC, France Oral Communications - Workshop Timeliness in CRs – does the extension of statistics publication time make sense? Maciej Trojanowski Poland Early cancer incidence estimates improve timeliness of cancer incidence reporting by one year Harlinde De Schutter Belgium Timeliness of childhood cancer registration in Switzerland: the impact of the cancer registration act Yara Shoman Switzerland Introduction of HPV screening for cervical cancer: challenges and opportunities from the cancer registry perspective Koen Van Herck Belgium Q&A
15:45 - 16:15	Coffee Break & Poster Visit
16:15 - 17:15	Session 3 - Statistical Methods Co-moderators: Valérie Jooste GRELL SC representative France & Freddie Bray IARC, France Keynote speaker 2 Projections and detailed trend analyses of cancer incidence or mortality using multidimensional penalized splines Zoe Uhry France Oral Communications - Workshop Validity of projections of new cancer cases in Austria Petra Ihle Austria Methodology to estimate the incidence of cancer in Spain in the current year. A collaborative study of REDECAN Alberto Ameijide Spain Q&A
17:30 - 18:30	CLOSED SESSION: HEAD OF CANCERWATCH MEETING
	Free Time

Wednesday, May 28^th

08:15 - 09:00

Registration & Posters Visit

09:00 - 09:20

Opening Session

Claudine Backes GRELL President & Liesbet van Eycken ENCR Co-Chair & Manola Bettio JRC & Maria José Bento North Region Cancer Registry of Portugal (RORENO) Director & Júlio Oliveira Board President of IPO Porto

09:20 - 10:30

Session 1 - The European Health Data Space

Co-moderators: Giske Ursin ENCR SC representative Norway & Koen Van Herck GRELL SC representative Belgium & Tiago Taveira-Gomes University of Porto

Keynote speaker 1

The European Health Data Space (EHDS): A new era for healthcare in Europe

Anne Calteux Head of Representation at Representation of EU Commission to Luxembourg

Keynote speaker 2

Cancer Registries in the European Health Data Space

Hanneke A. Luth Erasmus MC, The Netherlands

Q&A

10:30 - 11:00

Coffee Break & Posters Visit and Flash Talks

Data Quality I Room 1 Co-moderators: Marià Carulla GRELL SC representative Spain & Maciej Trojanowski ENCR SC representative Poland	Survival I Room 2 Co-moderators: María-Dolores Chirlaque ENCR SC representative Spain & Valérie Jooste GRELL SC representative France
Completeness evaluation of adult population-based cancer registries. A systematic review. Mariana Pinto Sousa Portugal	Survival in Adolescents and Young Adults with cancer compared with children and adults in Europe: a EUROCARE6 study Annalisa Trama Italy
Correcting uterine cancer mortality in Estonia using linkage of cancer registry data Kaire Innos Estonia	Exploring previous pregnancy impact on breast cancer stage, treatment and survival Laia Barrachina-Bonet Spain

11:00 - 12:15

Session 2 - EXposure, Cancer Etiology & Screening

Co-moderators: Volker Arndt ENCR SC representative Germany & Anne Cowppli-Bony GRELL SC representative France

Oral Communications

Do wildfires impact the incidence of cancer? - a Portuguese study

Rita Calisto Portugal

Communicating Epidemiological Research on Environmental Cancer Risks: Lessons from Slovenian Cancer Registry

Amela Duratović Konjević Slovenia

The impact of Hepatocelular carcinoma etiologies on Madeira Islands, Portugal

Pedro Berenguer Portugal

Characteristics of post-colonoscopy versus interval colorectal cancers in participants of organized FIT screening

Koen Van Herck Belgium

Increasing burden of HPV-related cancers in Estonia

Keiu Paapsi Estonia

Q&A

12:15 - 13:30

Lunch Break & Poster Visit and Flash Talks

Epidemiological and clinical use of cancer registry data I Room 1 Co-moderators: Freddie Bray ENCR SC representative IACR & Leticia Fernández GRELL SC representative Cuba	New methods innovation and AI applications Room 2 Co-moderators: Gijs Geleijnse ENCR SC representative The Netherlands & Rita Calisto GRELL SC representative Portugal
MONITORING AND IMPROVING SKIN MELANOMA CARE MANAGEMENT IN SLOVENIA WITH QUALITY OF CARE INDICATORS Katarina Lokar Slovenia	The UK-US Childhood Cancer Pilot: Enabling International Cancer Registry Collaborations with Privacy-Enhanced Analytics Gijs Geleijnse UK
Pancreatic cancer patients with vague symptoms have later stage disease, fewer treatment options and poorer survival. Damien Bennett North Ireland	The OMOP Common Data Model as a facilitator for FAIRification of Population-Based Cancer Registries Siri Larønningen Norway
Causes of death in survival analysis of cancer patients Gemma Gatta Italy	Feasibility to analyze hormone receptors status from breast cancer pathological reports via automated techniques Hibah Abdulaziz A. Alshaya Scotland
COVID-19 and changes in the cancer incidence rates in Baden-Württemberg (Southwest Germany) in 2020-2023 Lina Jansen Germany	Can synthetic data mirror the structure and outcomes of cancer registry data Hannah Baltus Germany
Epidemiological causal models and their generalizabilty: a use case to study long-term effects in young cancer survivors Alice Bernasconi Italy	Modernizing Morocco's Cancer Registry with a Full-Web Information System Zineb Gaizi Morocco

13:30 - 14:30

Session 3 - Survival

Co-moderators: Valérie Jooste GRELL SC representative France & Maciej Trojanowski ENCR SC representative Poland

Oral Communications

Breast cancer survival by subtype, stage at diagnosis and socioeconomic status among young women in Madrid, Spain

Candela Pino Rosón Spain

Flexible penalized relative mortality models for modelling under-mortality in early-stage prostate cancer patients

Mathieu Fauvernier France

Cancer survival estimation using population-based data: biases and pitfalls

Laura Botta Italy

Survival and Prevalence of Cancer in Adolescents and Young Adults (AYAs) in Switzerland

Aaron Renggli Switzerland

Q&A

14:30 - 15:00

Coffee Break & Poster Visit and Flash Talks

Age and Cancer & Screening Room 1

Co-moderators: Antonia Sánchez GRELL SC representative Spain & Laura Ortelli GRELL SC representative Switzerland

Years of life lost due to cancer in the UK, 2023

Eszter Jardan England

Impact of the COVID-19 pandemic on Northern Ireland breast cancer patients’ referral and treatment pathways

Hellen Mitchell North Ireland

15:00 - 16:15

Session 4 - Cancer incidence & results from new cancer registries

Co-moderators: Marcela Guevara GRELL SC representative Spain & Lúcio Lara-Santos IPO Porto

Oral Communications

Semi-automated monitoring of trends in incidence and stage distribution for enhanced timeliness in cancer control

Hanna M Peacock Belgium

Forecasting Lung Cancer Incidence in Slovenia: Age-Period-Cohort Analysis with Smoking Data

Maja Jurtela Slovenia

Combined Cancer Distribution by Anatomical Site and Sex in Cape Verde (2022-2023)

Cátia Mendonça Cape Verde

Colorectal Cancer Incidence Projections in Brazil: Challenges and Perspectives for 2030- 2040

Rejane de Souza Reis Brazil

Q&A

16:15 - 16:45

Session 5 - Grell General Assembly (for GRELL members)

18:15

Welcome Drink & Boat Tour

Thursday, May 29^th

08:15 - 09:00

Welcome & Posters Visit

09:00 - 10:00

Session 6 - Future of Cancer Registries - Perspectives from clinicians

Co-moderators: Marta Soares IPO-Porto, Portugal & Liesbet van Eycken ENCR SC representative Belgium & IACR & Arnaud Alves University Hospital Centre Caen Department of Digestive Surgery, France

Keynote speaker 1

Future of Cancer Registries – Perspectives from clinicians

Riccardo Audisio University of Gothenburg, Sweden

Abstract or panel session

Q&A

10:00 - 10:30

Coffee Break & Posters Visit and Flash Talks

Prevention Room 1 Co-moderators: Giske Ursin ENCR SC Norway & Koen Van Herck GRELL SC Belgium	Social inequalities and cancer I Room 2 Co-moderators: Volker Arndt ENCR SC Germany & Anne Cowppli GRELL SC France
Population Attributable Factors related to cancers incident in Luxembourg: a RELIANCE pilot study Bruno Lima Luxembourg	Inequalities in cancer risk among migrant populations in a region of southeastern Spain María Dolores Chirlaque Spain
Trends in the fraction of cancer attributable to air pollution in the UK and its constituent nations, 2003-2023. Sofia Migues England	Use of mortality tables by level of deprivation in the study of social inequalities in cancer survival Joséphine Gardy France
Population attributable fractions for smoking related cancers in Ireland in 2022 Laura Finneran Ireland

10:30 - 11:30

Session 7 - Cancer and cure

Co-moderators: María Dolores Chirlaque ENCR SC representative Spain & Dana Coza GRELL SC representative Romania

Oral Communications

Time to cure and follow-up recommendations in breast and colorectal cancer in Tarragona, Spain

Marià Carulla Aresté Spain

Indicators of cancer cure in Europe by geographical area and stage: results from the EUROCARE-6 study

Elena Demuru Italy

Quality indicators for prostate cancer care. A population-based study in southern Switzerland

Laura Ortelli Switzerland

Risk of metastatic recurrence in Italian women with breast cancer using populationbased data: a modelling approach

Fabiola Giudici Italy

Q&A

11:30 - 12:30

Session 8 - Epidemiological and clinical use of cancer registry data

Co-moderators: Deirdre Murray ENCR SC representative Ireland & Leticia Fernandez GRELL SC representative Cuba

Oral Communications

Improving lung cancer risk assessment in primary care patients with cough or dyspnoea using prescriptions data

Marta Berglund UK

Pre-existing Anxiety/Depression or Painful Conditions, imaging investigations and emergency lung cancer diagnosis risk

Helen Fowler UK

Evolution of microsatellite instability testing in colorectal cancer using French digestive cancer registry data

Joséphine GARDY France

Cause specific mortality within the first years of follow-up after diagnosis of cancer

Volker Arndt Germany

Q&A

12:30 - 13:45

Lunch Break & Posters Visit and Flash Talks

Epidemiological and clinical use of cancer registry data II Room 1 Co-moderators: Deirdre Murray ENCR SC representative Ireland & Marcela Guevara GRELL SC Spain	Epidemiological and clinical use of cancer registry data III Room 2 Co-moderators: Liesbet van Eycken ENCR SC Belgium & Dana Coza GRELL SC Romania
Differentiating population-based palliative care needs in cancer patients using cancer registry data Teja Oblak Slovenia	The impact of the COVID-19 pandemic on cancer incidence, survival, stage and healthcare outcomes in Switzerland Katharina Staehelin Switzerland
Pre-diagnostic consultations and imaging investigations in emergency-diagnosed vs referred lung cancer patients Marta Berglund England	Second primary cancers among males with a first primary prostate cancer: A population-based study in Northern Portugal José Taveira-Barbosa Portugal
Availability and completeness of cancer registries’ stage information provided to the European Cancer Information System Cristina Bosetti Italy	Incidence and stage at diagnosis of childhood and adolescent cancer between 2015-2020 in the Community of Madrid, Spain Clotilde Sevilla Hernández Spain
Incidence trends of early-onset colorectal malignancies in Germany: A registry-based study from 1994 to 2021 Sven Voigtländer Germany	Epidemiology of female metastatic breast cancer between 1993 and 2022 in the Federal state of Saarland, Germany Natalie Rath Germany
Recognition as a Paediatric Oncology Reference Centre: A Data-Driven Approach Using Cancer Registry Insights Bárbara Peleteiro Portugal	Breast cancer progression: retrospective cohort of 8578 women in UK cancer registries Zoe Bradford Scotland

13:45 - 15:00

Session 9 - Age and cancer

Co-moderators: Freddie Bray ENCR SC representative IARC & Antonia Sanchez Gil GRELL SC representative Spain

Oral Communications

Childhood tumours and congenital anomalies: possible association and impact on survival

Carmen Martos Spain

Survival after childhood neuroblastoma in mainland France (2000-2016) – a national registry-based study

Claire Poulalhon France

Childhood and adolescent cancer survival 1998-2017. A population-based study from the Italian cancer registries

Gemma Gatta Italy

Linking population-based and national clinical pediatric cancer registries on neuroblastoma: the BENCHISTA-ITA project

Fabio Didonè Italy

Trends in Childhood Cancer Incidence and Mortality Rates: 60th years of experience in Cali, Colombia

Elvia Karina Grillo Colombia

Q&A

15:00 - 15:30

Coffee Break & Posters Visit and Flash Talks

Data quality II Room 1 Co-moderators: Manola Bettio ENCR JRC & Alexandra Mayer da Silva GRELL SC Portugal	Social inequalities and cancer II Room 2 Co-moderators: Laetitia Daubisse-Marliac ENCR SC representative France & Anne Cowppli GRELL SC representative France
ENHANCING CANCER REGISTRATION IN SLOVENIA: A SWOT-BASED EVALUATION OF ACTIVE CASE-FINDING AND DIGITAL PROCESS MAPPING Tina Žagar Slovenia	Incidence rates of tobacco related cancers by deprivation quintile in Ireland 2014 to 2018 Laura Finneran Ireland
Completeness of case ascertainment in the Swiss Childhood Cancer Registry Aaron Renggli Switzerland	Liver cancer burden in Europe with a focus on histological subtype patterns Giorgia Randi Italy

15:30 - 16:30

Session 10 - Social inequalities and cancer

Co-moderators: Maria José Bento IPO-Porto, Portugal & Laura Ortelli GRELL SC representative Switzerland

Oral Communications

Impact of Cancer Diagnosis on Employment in Austria

Monika Hackl Austria

Are prostate cancer grade and initial prognosis socially patterned? Data from the Tarn Cancer Registry over 2006-2021

Sebastien Lamy France

Cancer RADAR – mapping cancer risk among individuals with a migration background across Europe

C.J. Alberts Netherlands

World-wide patterns of care and time to treatment for ovarian cancer – VENUSCANCER

Veronica Di Carlo UK

Q&A

16:30 - 17:30

Session 11 - ENCR-JRC activities and scientific updates

19:30

Gala Dinner

Friday, May 30^th

08:45 - 09:00

Welcome

09:00 - 09:45

Session 12 - Digital Tools

Co-moderators: Maria Teresa Pesce GRELL SC representative Switzerland & Gijs Geleijnse ENCR SC representative The Netherlands

Keynote speaker 1

Future of Cancer Registries and Digital Tools

Ricardo Correia Health Informatics, University of Porto, Portugal

Q&A

09:45 - 10:15

Coffee Break & Posters Visit and Flash Talks

Survival II Room 1

Co-moderators: Marià Carulla GRELL SC representative Spain & Maciej Trojanowski ENCR SC representative Poland

Long-term survival of breast cancer patients by stage at diagnosis in Europe: EUROCARE-6 results

Silvia Rossi Italy

Survival in synchronous or metachronous oligometastatic and polymetastatic NSCLC - a cancer registry analysis

Antje Schliemann Germany

Trends in survival from lung cancer in a Northern Italian region: a population-based study

Federica Zamagni Italy

10:15 - 11:15

Session 13 - Data Quality

Co-moderators: Laetitia Daubisse-Marliac ENCR SC representative France & Alexandra Mayer da Silva GRELL SC representative Portugal

Oral Communications

Approaches to handle missing follow-up time: A comparative analysis of contralateral breast cancer incidence

Sarah Haile Switzerland

Assessment of WHO’s International Classification of Health Interventions as a Standard for Cancer Registry Procedures

Matthijs Sloep The Netherlands

Quality indicators over time of European cancer registries data submitted to the European Cancer Information System

Joanna Julia Bartnicka Italy

Q&A

11:15 - 12:30

Session 14 - New Methods, innovation and AI applications

Co-moderators: Robin Schaffar GRELL SC representative Switzerland & Manola Bettio ENCR – JRC representative

Oral Communications

Privacy-preserving self-service linkage of cancer registry and socioeconomic data in a safe processing environment

Siri Larønningen Norway

The impact on net survival estimates of different approaches to modelling life tables – insights from CONCORD-4

Veronica Di Carlo UK

CANCER RECURRENCE, PROGRESSION AND TRANSFORMATION– NEW ENCR GUIDELINES FOR POPULATION-BASED CANCER REGISTRIES

Anna Gavin North Ireland

Leveraging Generative AI for Survival Analysis on Synthetic Breast Cancer Data from European Cancer Registries

Dimitris Katsimpokis Italy

Stage Shift in Cervical Cancer: COVID or FIGO?

David Morrison Scotland

Q&A

12:30 - 12:45

Meeting Closing

Award for the best oral communication and poster for young researchers

12:45 - 14:00

Standing Lunch

Abstracts Submission Instructions

Researchers from Population-based Cancer Registries of latin countries and from ENCR member states are invited to submit abstracts for oral communications and posters of the GRELL-ENCR Scientific Meeting.

We ask authors to follow these instructions scrupulously to facilitate the compilation of abstracts.

Instructions for authors

The abstract must be written in English.
The title of the abstract should contain no more than 120 characters (including spaces).
A maximum of 10 authors belonging to up to five different institutions should be specified. The authors will be separated by semicolon(;), indicating name and surname, without indication of the academic title (see example below).
The body of the abstract should contain no more than 2000 characters (including spaces).
The abstract should include the following parts: Objectives, Methods, Results and Conclusions.
The abstract should not contain any table or figure, nor references.
The abstract must be submitted using the form available below.
Authors may indicate a preference for the type of presentation: Poster or Oral communication. Participants who are going to present an oral communication will be asked for consent to broadcast the communication via streaming (audio and slides).
If the abstract is accepted, at least one if the authors must be registered at the conference.
Presenters need to attend the conference in person
Abstracts will be evaluated by a Scientific Committee which will decide the acceptance of contributions and the mode of presentation.
Notification of acceptance or rejection of the abstract will be sent to the author indicated for correspondence, up to two weeks after the deadline for submission.

Themes for Abstract Submission

Social inequalities and cancer
Age and cancer
Cure and care
Survival
Epidemiological/clinical use of cancer registry data
Data quality
New methods, innovation, and AI applications
Cancer Etiology
Screening
Results from new cancer registries
Environmental and occupational exposure and cancer
Strategies to enhance timeliness on cancer registries

Best oral and poster communication awards

The best oral communication and the poster presented at the meeting by a young (under 35 years old) GRELL researcher will be awarded a prize consisting on the fees reimbursement.

NEW Deadline for submission of abstracts: 30^th of March 2025.

Abstract acceptance notification: 15^th of April 2025.

Each contribution will be assessed independently by two reviewers. Only contributions aiming to issues inherent to population cancer registries will be accepted.

We seek to ensure a maximum representation of cancer registries of Latin languages countries accredited or in process of accreditation.

Multiple contributions from the same institution will be evaluated on the basis of the relevance of the topics covered and the availability of oral communications.

Abstract submission Ended!

Thank you

Download Book of Abstracts

Support

Scientific Committee

Rita Calisto
GRELL & IPO PORTO

Portugal

Maria José Bento
IPO PORTO

Portugal

Claudine Backes
GRELL & ENCR

Luxembourg

Valérie Jooste
GRELL

FRANCE

Marià Carulla
GRELL

SPAIN

Liesbet van Eycken
ENCR

Belgium

Gijs Geleijnse
ENCR

The Netherlands

Manola Bettio
JRC

Raquel Carvalho
JRC

Organization Committee

Rita Calisto
GRELL & IPO PORTO

Portugal

Maria José Bento
IPO PORTO

Portugal

Anabela Sousa

Portugal

Roxanne Garcia

Portugal

Ana Filipa Gonçalves

Portugal

Teresa Garcia

Portugal

Pedro Leite Silva

Portugal

Ana Catarina Rodrigues

Portugal

Claudine Backes
GRELL & ENCR

Luxembourg

Support

Workshop 1

“ICD-O-4: towards application in population-based cancer registries”

Description soon

Workshop 2

Is your data available for this year? Strategies to enhance timeliness at population-based cancer registries

Timeliness refers to how quickly cancer data can be collected, processed, and reported. There is commonly a trade-off between timeliness and the completeness and validity of the data. The workshop will explore the concept of timeliness at the population-based cancer registry, alongside the challenges and solutions – from enhanced methods of operation at the registry through to statistical estimates based on extrapolations of the collected data.

Grants GRELL

In the last years it has been possible to request financial aid to participate at the “Ascension Reunion” GRELL’s annual meeting.

The elegible persons are mainly young researchers or recent cancer registry groups representants from latin language countries and/or other participant countries. Our goal is to give young researchers the opportunity to show their research and their work in order to integrate our scientific community. Other situations might also be considered.
The deadline for submitting grant applications is the same as the deadline for submitting abstracts.

To apply, download the application form below, and send it to:

info@grell-network.org

Application Form GRELL

Grants ENCR

The European Commission Joint Research Centre (JRC) is sponsoring the GRELL-ENCR Scientific Meeting 2025, covering part of the organisation and catering.

A limited budget is available for financial support to cover for travel and/or accommodation of participants with an accepted scientific abstract, coming from cancer registries that are part of the European Network of Cancer Registries.

Please note that the JRC cannot support the registration fee to the GRELL-ENCR Scientific Meeting.

Support may be requested by filling in this application form. If the number of requests for financial support will exceed the available budget, preference will be given according to the conditions below:

Applicant submitted an abstract to the conference (not necessarily as 1st author)
Applicant affiliated with a ENCR cancer registry
Applicant coming from a lower-income European country
a single applicant per Organisation
date of application received

Depending on the number of requests, support may be restricted to travel or accommodation.

Please complete the application in English. All relevant information should be included in the electronic form.

Application Form ENCR

Best oral and poster communication awards

The best oral communication and the poster presented each year at the GRELL meeting by a young (under 35 years old) researcher are awarded a prize consisting on the fees reimbursement for that year’s Meeting.

The presentations are evaluated by a Sub-Committee elected from the members of the Scientific Committee of the GRELL, composed of at least three members from different countries.

Guidelines Last Winners

Best ENCR Poster Awards

The ENCR Steering Committee will select the best poster communications presented at the meeting by a ENCR researcher for the Best Poster Awards

Congress

geral@lab52.pt
eventos@lab52.pt

Scientific

grell.encr.2025@ipoporto.min-saude.pt

EARLY REGISTRATION

CLOSED

Limited seats reached

Participants aged 35 years and aboveUntil April 16^th

€ 165,00

Includes:

Access to Lectures
Workshops
Documentation Folder
Lunch
Coffee Break
Certificate of Attendance
GRELL Membership
Welcome Drink

Participants younger than 35 Years OldUntil April 16^th

€ 115,00

Includes:

Access to Lectures
Workshops
Documentation Folder
Lunch
Coffee Break
Certificate of Attendance
GRELL Membership
Welcome Drink

LATE REGISTRATION

CLOSED

Limited seats reached

Participants aged 35 years and aboveAfter April 16^th

€ 215,00

Includes:

Access to Lectures
Workshops
Documentation Folder
Lunch
Coffee Break
Certificate of Attendance
GRELL Membership
Welcome Drink

Participants younger than 35 Years OldAfter April 16^th

€ 165,00

Includes:

Access to Lectures
Workshops
Documentation Folder
Lunch
Coffee Break
Certificate of Attendance
GRELL Membership
Welcome Drink

Registration Deadline: 12^th May 2025

Attention: Limited Seats Available

European countriesSTREAMING

€ 115,00

Includes:

Access to Digital Lectures
Digital Congress Material
GRELL Membership

Non-European countriesSTREAMING

€ 75,00

Includes:

Access to Digital Lectures
Digital Congress Material
GRELL Membership

*Registration Deadline: 12^th May 2025

Supporting Registrations

€ 20,00

Includes a voluntary contribution to support travel awards to the GRELL_ENCR 2025 conference for students or low/middle-income countries.

Registration Closed!

Thank you

13 Dezembro, 2024

Love0

Ginecologia Oncológica

By admin1990Terminado

9º Curso Avançado

Ginecologia Oncológica

É com entusiasmo que damos as boas-vindas ao 9º Curso Avançado de Ginecologia Oncológica de 2024. Será uma oportunidade única para profissionais de saúde compartilharem conhecimento e explorarem os mais recentes avanços no tratamento ginecológico. O mesmo irá decorrer no Instituto Português de Oncologia do Porto (IPO Porto) nos dias 27 e 28 de junho de 2024.

Com um programa científico abrangente, conta com palestras e mesas-redondas conduzidas por especialistas de renome. Esperamos promover a colaboração entre diferentes profissionais, para melhorar o cuidado prestado ao doente oncológico.

Especialista27 & 28 DE JUNHO

€ 75,00

Inclui:

Palestras da sessão Plenária
Almoço
Coffee Break
Pasta de Congresso
Certificado de Presença

Interno27 & 28 DE JUNHO

€ 40,00

Inclui:

Palestras da sessão Plenária
Almoço
Coffee Break
Pasta de Congresso
Certificado de Presença

Estudante27 & 28 DE JUNHO

€ 20,00

Inclui:

Palestras da sessão Plenária
Almoço
Coffee Break
Pasta de Congresso
Certificado de Presença

Inscrições limitadas à capacidade do auditório
Inscrições disponíveis até 25 de junho 2024

	27 de junho — Quinta-Feira 27^th June 2024 — Thursday

09.00h	Sessão de Abertura \| Opening Session CA IPO Porto, Deolinda Pereira, Almerinda Petiz, Luísa Carvalho

09.20h	Carcinoma do ovário I \| Ovarian cancer I Moderadores/Chairs: Lúcia Correia, Fátima Vaz, Gabriela Soares, Raquel Portugal

09.20h	Estadiamento cirúrgico após quimioterapia neoadjuvante: o que é necessário fazer em 2024? \| Hugo Gaspar Surgical staging after neoadjuvant chemotherapy: what we need to do in 2024?

09.40h	Fatores prognósticos e preditivos após quimioterapia neoadjuvante \| Mafalda Casanova Prognostic and predictive factors after neoadjuvant chemotherapy

10.00h	Na era dos painéis genómicos: pesquisar mutação BRCA apenas? \| Ana Luísa Peixoto In the era of genomic panels: search for BRCA mutations only?

10.20h	Discussion \| Discussion

10.40h	Coffee Break

11.00h	Carcinoma do ovário II \| Ovarian cancer II Moderadores/Chairs: Miguel Abreu, Sérgio Castedo, Cristina Frutuoso, Filomena Pina

11.00h	Retestar mutações BRCA das doentes mutadas na recidiva? \| Ana Barbosa Retest BRCA mutations of BRCA-mutated patients on relapse?

11.20h	Na era dos inibidores da PARP, como abordar a oligoprogressão? In the era of PARP inhibitors, how to approach oligoprogression?

	Visão da Cirurgia/Ginecologia \| Cristina Frutuoso Surgery/Gynaecology perspective
	Visão da Radioncologia \| Isabel Rodrigues Radiation Oncology perspective

12.10h	Discutindo as intervenções cirúrgicas e endoscópicas nos quadros oclusivos \| Licínio Rego Discussing the surgical and endoscopic interventions in bowel obstruction

12.25h	Discussion \| Discussion

12.45h	Almoço \| Lunch

14.00h	Carcinoma do endométrio \| Endometrial cancer Moderadores/Chairs: Mónica Pires, Carla Bartosch, Luísa Carvalho, Susana Sousa

14.00h	Alterações moleculares: que implicações na prática clínica \| Carla Pinto Molecular changes: what implications for clinical practice

14.20h	Indicação para cirurgia no estádio IV \| João Casanova Surgery indication in stage IV

14.40h	Avanços no tratamento médico paliativo na era da classificação molecular \| Willem Jan van Weelden Advances of palliative systemic treatment in the era of molecular classification

15.00h	Discussion \| Discussion

15.20h	Conferência \| Conference Moderadores/Chairs: Jaime Cardoso, Mónica Nave

	Aplicação da Inteligência Artificial no Cancro Ginecológico \| Diana Montezuma Application of Artificial Intelligence in Gynaecological Cancer

16.10h	Coffee Break

16.30h	Grupo multidisciplinar \| Multidisciplinary Tumour Board Moderadores/Chairs: Ana Félix, Vanda Patrício, Isabel Reis; Catarina Portela

16.30h	Caso Clínico 1: Carcinoma do colo do útero - Traquelectomia \| António de Pinho Clinical Case 1: Cervical cancer – Trachelectomy

16.50h	Discussion \| Discussion

17.05h	Caso Clínico 2: Carcinoma do Ovário \| Marta Vaz Batista Clinical Case 2: Ovarian cancer

17.25h	Discussion \| Discussion

	28 de junho — Sexta-Feira 28^th June 2024 — Friday

09.00h	Carcinoma do colo do útero \| Cervical cancer Moderadores/Chairs: Olga Sousa, Marta Ferreira, Paulo Aldinhas

09.00h	Qual o melhor tratamento radical? \| Edgar Petru What is the best radical treatment?

	Quimio-radioterapia com imunoterapia? Chemoradiotherapy with immunotherapy?
	Quimioterapia de indução seguida de quimio-radioterapia? Induction chemotherapy followed by chemoradiotherapy?

09.30h	Radioterapia intra-operatória \| Dora Gomes e Susana Costa Intraoperative radiation therapy

09.50h	Sequência do tratamento sistémico após 1ª linha paliativa de quimioterapia em associação com imunoterapia \| Raúl Márquez Vásquez Sequence of systemic treatment after 1st line palliative chemotherapy in association with immunotherapy

10.10h	Discussion \| Discussion

10.30h	Conferência \| Conference Moderadores/Chairs: Deolinda Pereira, Sofia Fragoso, Joana Assis

	Oncologia de Precisão no Cancro Ginecológico: para onde vamos? \| Ana Rita Lopes Precision Oncology in Gynaecological Cancer where are we going?

11.00h	Coffee Break

11.30h	Mesa Redonda \| Round Table Cuidar de quem cuida \| Take care of caregivers and health professionals Moderadores/Chairs: Susana Almeida, Paula Silva, Sónia Castro, Joana Bordalo Sá

	Perspetiva do profissional de saúde \| Débora Filipe Healthcare professional's perspective

	Perspetiva do cuidador \| Cristina Coelho Caregiver's perspective

12.15h	Painel \| Panel Moderadores/Chairs: Deolinda Pereira, Almerinda Petiz

	Centros de Referência Multidisciplinares em Ginecologia Oncológica em Portugal: em que ponto estamos? \| Henrique Nabais, Ana Braga, Teresa Carvalho, Gonçalo Fernandez, Sofia Maia, José Dinis Multidisciplinary Reference Centers in Gynaecologic Oncology in Portugal: where are we?

13.15h	Sessão de encerramento e entrega de prémios \| Closing session and award ceremony

Download Programa

Regras para Submissão de Trabalhos Científicos

Os trabalhos científicos deverão corresponder ao âmbito da temática do 9º Curso Avançado Ginecologia Oncológica.

01. Estrutura

Deverá ser utilizado o template word que se encontra no final desta página. Por favor faça download e preencha respeitando a estrutura e exemplos do mesmo:

Título do trabalho;
Nome, apelido, local de trabalho dos autores e email;
Escolha da temática pretendida com a seguinte estrutura:

Séries Clínicas – Introdução, Descrição, Discussão e Conclusão.
Casos Clínicos – Introdução, Descrição, Discussão e Conclusão.
Ciências Básicas – Introdução, Descrição, Discussão e Conclusão.

O conteúdo do resumo não deverá ter a identificação de nenhum dos autores ou fazer alusão a qualquer outro dado que possa comprometer o anonimato. Poderá conter até um máximo de 2500 caracteres, incluídos espaços, respeitando o acordo ortográfico em vigor.

02. Candidatura

Os resumos dos trabalhos científicos deverão ser enviados até ao dia 11 de junho 2024 em formato PDF para: eventos@lab52.pt.
Serão notificados todos os autores até ao dia 19 de junho 2024 sobre a aceitação do trabalho.
Até 21 de junho 2024 pelo menos um dos autores terá que estar inscrito no congresso.

03. Formato

Todos os trabalhos aceites serão apresentados em forma de e-poster.
Será disponibilizado template Powerpoint para a sua realização. Este template já se encontrará dimensionado corretamente para o bom funcionamento e visualização. A organização não se responsabiliza pelo não funcionamento ou falta de qualidade dos e-posters elaborados noutros programas ou formatos.
Os trabalhos serão exibidos num ecrã no dia do evento. Deverão ser enviados em formato JPG até ao dia 25 de junho 2024 para eventos@lab52.pt.

04. Prémios

Serão atribuídos o 1º e 2º prémio (500,00€ e 350,00€) aos melhores trabalhos científicos de cada área temática. A divulgação dos vencedores será feita na sessão de encerramento no dia 28 de junho 2024. Pelo menos um dos autores deverá estar presente na sessão sob pena de não receber o prémio atribuído.

Download template

Organização

Apoio

Brevemente

IPO-Porto

Instituto Português de Oncologia do Porto FG, EPE

O IPO-Porto tem como missão a prestação de cuidados de saúde, em tempo útil, centrados no doente, não descurando a prevenção, a investigação, a formação e o ensino no domínio da oncologia com o objetivo de garantir elevados níveis de qualidade, humanismo e eficiência.

Contactos

R. Dr. António Bernardino de Almeida 865,
4200-072 Porto,
Portugal
(+351) 225 084 000
www.ipoporto.pt

Lígia Silva
(+351) 914 592 380

Email
eventos@lab52.pt

Email
geral@lab52.pt

Inscrições Encerradas!

Obrigado.

18 Março, 2024

Love0

Current Concepts in Head and Neck Cancer 2024

By admin1990Terminado

Current Concepts in Head and Neck Cancer 2024

Celebrating the past by looking to the future

The 3^rd edition of the “Current Concepts on Head and Neck Cancer” meeting, taking place on April 11th -13th, 2024, is part of the 50th anniversary celebrations of the Portuguese Institute of Oncology at Porto. In honor of the institutional mission of promoting the constant updating of knowledge, teaching and research, “Celebrating the past by looking to the future” is the purpose, for which we have a panel of experts in the area of Head and Neck Cancer from MD Anderson Cancer Center, reviving what was once a tradition at IPO Porto. Renata Ferrarotto, Jack Phan, Ehab Hanna and Rene Largo join Jatin Shah, who once again chairs the meeting. MD Anderson and MSKCC in Portugal to promote the sharing of experience in the treatment of Head and Neck Cancer, namely Cancer of the Oral Cavity, Oropharynx, Thyroid, Salivary Glands and Skin. It is in this multidisciplinary environment that we welcome you, including all those who dedicate themselves to patients with Head and Neck Cancer.

The Organizing Committee

A 3ª edição da reunião “Current Concepts on Head and Neck Cancer”, a decorrer nos dias 11 a 13 de Abril de 2024, integra as comemorações dos 50 anos do Instituto Português de Oncologia do Porto. Em homenagem à missão institucional de promover a actualização constante de conhecimentos, o ensino e a investigação, “Celebrating the past by looking to the future “ é o propósito, para o qual contamos com um painel de experts na área de Cancro da Cabeça e Pescoço do MD Anderson Cancer Center, revivendo aquilo que já foi uma tradição no IPO Porto. Renata Ferrarotto, Jack Phan, Ehab Hanna e Rene Largo juntam-se a Jatin Shah, que mais uma vez preside a reunião. MD Anderson e MSKCC em Portugal para promover a partilha de experiência no tratamento do Cancro da Cabeça e Pescoço, nomeadamente Cancro da Cavidade Oral, Orofaringe, Tiroide, Glândulas Salivares e Pele. É neste ambiente multidisciplinar que vos recebemos, contando com todos aqueles que se dedicam aos doentes com Cancro da Cabeça e Pescoço.

A Comissão Organizadora

Physician11^th & 12^th April

€ 175,00

Includes:

Access to Lectures
Documentation Folder
Lunch
Coffee Break
Certificate of Attendance

Resident11^th & 12^th April

€ 90,00

Includes:

Access to Lectures
Documentation Folder
Lunch
Coffee Break
Certificate of Attendance

Industry Non Sponsor11^th & 12^th April

€ 300,00

Includes:

Access to Lectures
Documentation Folder
Lunch
Coffee Break
Certificate of Attendance

*Registration Deadline: 5^th April 2024

13^th April - Meet the Professor

National Clinical Cases Presentation and Discussion

Tour on the Douro River to Pinhão

National Clinical Cases

Lunch on Board

Bus Return Trip To Porto

On Saturday, we promote the discussion of clinical cases, in an informal environment during a tour on the Douro River to Pinhão. During the morning, national guests will present clinical cases, covering the various areas of head and neck pathology, so that we can comment on them together with our panel of experts from MD Anderson and MSKCC. After lunch, we will have the opportunity to talk more freely with our international guests, share experiences and enjoy the scenery.

*Meeting on Saturday have conditions to be defined, depending on the number of participants.

Scientific Program

Thursday, April 11^th

08.30

Opening Ceremony
50 Years of Head and Neck Cancer Treatment | Jatin Shah
Chairs: Júlio Oliveira; Ana Espírito Santo; Jorge Guimarães: Sérgio Chacim

09.30

Career Journeys to Expertise and Research at MD Anderson and MSKCC
Chairs: Cláudia Araújo; Cláudia Vieira

10.30

Coffee Break

11.00

Oral Cavity
Chairs: Cristina Sanches; André Soares; Leonor Ribeiro

The Future of Oral Cancer Staging | Jatin Shah
Surgery After Induction Chemotherapy – MD Anderson Experience | Ehab Hanna
Role of Neoadjuvant Immunotherapy in Curative-Intent | Renata Ferrarotto
Locoregional Failure Following Post-Operative IMRT | Jack Phan

12.00

Lecture
Advances in Oral Cancer Reconstruction | Rene Largo
Chairs: Rui Barbosa; Ricardo Horta

13.00

Lunch

14.00

Salivary Glands
Chairs: Isabel Reis; Miguel Choupina; Pedro Gomes

Surgical Management | Jatin Shah
Parapharyngeal Tumors | Ehab Hanna
Current Concepts in Maxillary Reconstruction | Rene Largo
Proton Therapy for Major Salivary Gland Cancer: Clinical Outcomes | Jack Phan

15.00

Lecture
Salivary Gland Tumors: Molecular Characterization and Therapeutic Advances for Metastatic Disease | Renata Ferrarotto
Chairs: Isabel Fonseca; José Dinis

16.00

Coffee Break

16.30

Lecture
Larynx
Chairs: João Gagean; João Fernandes
Modern Conformal Radiotherapy Improving (Functional) Organ Preservation | Jack Phan

Friday, April 12^th

09.00

Skull Base
Chairs: Eduardo Netto; António Verdelho; Castro Silva

Open Surgery: When and How | Jatin Shah
SBRT for Skull Base Tumors | Jack Phan

09.40

Lecture
Skull Base Tumors: From Genomic to Therapeutic Strategies Advances | Ehab Hanna

10.30

Coffee Break

11.00

Recurrent and Metastatic Head and Neck Cancer
Chairs: Carlos Pinho; Guy Vieira; Margarida Teixeira; Miguel Magalhães

Immunotherapy and Beyond | Renata Ferrarotto
Role of Salvage Surgery | Ehab Hanna
Reconstruction in the Vessel Depleted Neck | Rene Largo

12.00

Lecture
Reirradiation Using Modern Highly Conformal Technique | Jack Phan

13.00

Lunch

14.00

Thyroid
Chairs: Inês Lucena; João Capela; Rui Barbosa

Current Practices and Controversies in the Management of Differentiated Thyroid Cancers | Jatin Shah
Tracheal Reconstruction | Rene Largo

15.30

Skin
Chairs: Matilde Ribeiro; Paula Ferreira

Treatment of the Neck in Non-Melanoma Skin Cancer | Ehab Hanna
Immunotherapy for Non-Melanoma Skin Cancer | Renata Ferrarotto

16.30

Late Bite

Saturday, April 13^th

08.00

Boarding at Cais da Estiva (Porto)

09.00

Breakfast on Board

09.15

Clinical Cases
Meet the Professor
Chairs: Jatin Shah; Ehab Hanna; Renata Ferrarotto; Rene Largo; Jack Phan

13.45

Lunch on Board

17.45

Arrival to Pinhão

18.00

Bus Trip to Porto

20.00

Arrival to Porto (Avenida dos Aliados)

On Saturday, we promote the discussion of clinical cases, in an informal environment during a tour on the Douro River to Pinhão. During the morning, national guests will present clinical cases, covering the various areas of head and neck pathology, so that we can comment on them together with our panel of experts from MD Anderson and MSKCC. After lunch, we will have the opportunity to talk more freely with our international guests, share experiences and enjoy the scenery

Jatin P. Shah
Head and Neck Surgery
Memorial Sloan Kettering Cancer Center

Ehab Hanna
Head and Neck Surgery
MD Anderson

Renata Ferrarotto
Medical Oncology
MD Anderson

Rene Largo
Plastic Surgery
MD Anderson

Jack Phan
Radiation Oncology
MD Anderson

Clinical Cases Submission

The organizing committee of the 3^rd Edition of the Current Concepts in Head and Neck Cancer challenges all national teams to submit a clinical case for discussion with our international experts in the session Meet the Professor. All cases of malignant pathology of the head and neck area including skin, thyroid and salivary glands will be considered. The case summary must be submitted electronically for the email eventos@lab52.pt, using the template available at the bottom of this page until March 23, 2024, at 24 hours. The text of the abstract, which must be in English, should not exceed 3000 characters, and should mention the relevance of the case. At least, one of the authors of the paper must be registered at the meeting and will be informed of the result of the selection by March 27.

The organizing committee will select the most pertinent one(s) for presentation on Saturday, April 13th, along with those already foreseen in the program, offering the first author the possibility to present his case and team to our panel of international guests, as well as the possibility of participating, free of charge, in the session Meet the professor. The rules for presentation will follow later.

All submissions will be recognized as “Clinical Case Submission” at the meeting and the winner(s) as “Oral Communication”.

A comissão organizadora da 3º edição da reunião Current Concepts in Head and Neck Cancer desafia todas as equipas nacionais a submeterem um caso clínico para discussão com os nossos experts internacionais no “Meet the Professor”. Serão considerados todos os casos de patologia maligna da área de cabeça e pescoço incluindo pele, tiróide e glândulas salivares. O resumo do caso deve ser submetido por via electrónica para o email eventos@lab52.pt, utilizando o template disponível no final desta página, até dia 23 de março de 2024, às 24 horas. O texto do resumo, obrigatoriamente em inglês, não deverá ultrapassar os 3000 caracteres, devendo referir a pertinência do caso. Pelo menos 1 dos autores do trabalho deverá estar inscrito na reunião e será informado do resultado da seleção até dia 27 de março.

A comissão organizadora seleccionará o(s) que considerar mais pertinentes para apresentação no sábado, dia 13 de abril, juntamente com os já previstos no programa, oferecendo ao primeiro autor a possibilidade de apresentar o seu caso e equipa ao nosso painel de convidados internacionais, assim como a possibilidade de participar, gratuitamente, no “Meet the Professor”. As normas para apresentação seguirão posteriormente.

Todas as submissões serão reconhecidas como “Submissão de Caso Clínico” na reunião e o(s) vencedor(es) como “Comunicação Oral”.

Clinical Cases Template

E-Poster Submission

In order to disclose clinical research in Portugal, on head and neck cancer, skin and thyroid cancer, the organization invites the various working groups to share clinical trials being recruited in the form of an e-poster.
The topic of the work must be in line with the theme of the meeting, and at least one of the researchers must be registered at the congress. The e-poster must be created using the template available at the bottom of this page, in a 16:9 format (1920 x 1080 pixels, vertical position).
The e-poster must be sent electronically to the email eventos@lab.52.pt in PowerPoint and PDF format by March 23, 2024 until 24h. The notification of its acceptance will be communicated by March 27, 2024.
The selected e-posters will be displayed during the meeting on 11^th and 12^th of April.

De forma a divulgar a investigação clínica em Portugal em cancro de cabeça e pescoço, pele e tiróide, a organização convida os vários grupos de trabalho para partilharem os ensaios clínicos em recrutamento sob a forma de e-poster.
O tema subjacente ao mesmo deverá enquadrar na temática da reunião, devendo pelo menos um dos investigadores estar inscrito no congresso.
O e-poster deverá ser executado através da utilização do template disponível no fundo desta página, numa proporção de 16:9 (1920 x 1080 pixels, posição vertical).
O e-poster deverá ser submetido via electrónica para o e-mail eventos@lab.52.pt em formato PowerPoint e PDF até dia 23 Março de 2024 às 24h, sendo efectuada a comunicação da sua aceitação até ao dia 27 Março 2024.
Os e-posters selecionados, estarão expostos durante os dias 11 e 12 de abril na reunião.

E-Poster Template

Organization

Support

Scientific Sponsors

Support

IPO Porto

Instituto Português de Oncologia do Porto FG, EPE

O IPO-Porto tem como missão a prestação de cuidados de saúde, em tempo útil, centrados no doente, não descurando a prevenção, a investigação, a formação e o ensino no domínio da oncologia com o objetivo de garantir elevados níveis de qualidade, humanismo e eficiência.

R. Dr. António Bernardino de Almeida 865,
4200-072 Porto, Portugal

(+351) 225 084 000

www.ipoporto.pt

Organizing Committee

Cláudia Araújo

Cláudia Vieira

Diana Moreira

Jorge Guimarães dos Santos

José Carlos Pereira

Marta Pina

Paula Pinto

Rita Félix

Rosa Capelo

Scientific Committee

Abreu de Sousa

Aida Cardoso

André Soares

Deolinda Pereira

Eurico Monteiro

Inês Lucena

Isabel Azevedo

Isabel Torres

José Dinis

Lúcio Lara Santos

Luís Medeiros

Luísa Carvalho

Manuel Jácome

Matilde Ribeiro

Olga Sousa

Otília Romano

Paula Alves

Paula Ferreira

Pedro Antunes

Rui Henrique

Rui Medeiros

Susana Dias

Teresa Bacelar

EUROSTARS OPORTO

The Eurostars Oporto Hotel is a modern, newly-built hotel boasting an optimal, strategic location very near the main entrances to the city and just 15 minutes from the airport. The Hospital São João, the most important universities and the Das Antas zone, the home to Oporto’s Do Dragão football stadium, are all just a few minutes away from the Oporto hotel. The modern, attractive building houses a highly functional hotel in Oporto with 64 apartments, ideal for longer stays, along with 6 meeting rooms, a restaurant, bar, television room, business centre and two parking zones (one indoor and one outdoor). Because of its location, features and comfort, it is a great option for both business and pleasure travel. The is also perfectly equipped for hosting all kinds of events from working meetings to conventions or banquets thanks to its numerous meeting rooms and their functionality.

CONTACTS
Rua do Mestre Guilherme Camarinha, 212
4200-537, Porto
Portugal
(+351) 225 072 090
reservas@eurostarsoporto.com
www.eurostarshotels.co.uk

Lígia Silva
(+351) 914 592 380

Email

eventos@lab52.pt

Email

geral@lab52.pt

REGISTRATION Ended!

Thank You!

19 Dezembro, 2023

Love0

6th BrEaST Cancer Weekend

By admin1990Terminado

6^th BrEaST Cancer Weekend

A Clínica de Mama do Ipo Porto tem muito gosto em anunciar a 6ª Reunião “O melhor do tratamento do cancro da mama em 2023”, a 2 e 3 de fevereiro 2024 no Auditório Principal do IPO Porto.

EspecialistasMÉDICOS

€ 85,00

Inclui:

Acesso às Palestras
Pasta c/ Documentação
Almoço
Coffee Break
Certificado de Presença

InternosMÉDICOS

€ 40,00

Inclui:

Acesso às Palestras
Pasta c/ Documentação
Almoço
Coffee Break
Certificado de Presença

EstudantesESTUDANTES

€ 20,00

Inclui:

Acesso às Palestras
Pasta c/ Documentação
Almoço
Coffee Break
Certificado de Presença

Programa Científico Provisório

2^nd February 2024 2 de fevereiro 2024

09:00h

Opening Session
Sessão Abertura
Júlio Oliveira; Ana Espírito Santo; Deolina Pereira; J. Abreu de Sousa

09:15h	Diagnosis controversies Controvérsias no diagnóstico J. Abreu de Sousa; José Carlos Marques; Paula Borralho; Ricardo da Luz
09:15h	Issues in biopsy diagnosis \| Cláudia Carneiro Questões nas biópsias diagnósticas
09:30h	Contrast mammography vs MRI \| Inês R. Pereira Mamografia com contraste vs ressonância magnética
09:45h	What is mandatory in a AP report \| Fernando Schmitt O que é obrigatório num relatório de Anatomia Patológica
10:00h	Discussion Discussão

10:15h

Coffee Break

10:45h	Locoregional treatment Tratamento locorregional Paulo Cortes; João Vargas Moniz; Cristina Gutiérrez
10:45h	Still axilla - Consensus in 2024 \| Salustiano González Ainda a axila – Consenso em 2024
11:00h	Can we de-escalate surgery? \| Pedro Antunes Podemos desescalar a cirurgia?
11:15h	Radiotherapy – less and less? \| Pedro Fernandes Radioterapia – cada vez menos?
11:30h	Discussion Discussão

11:45h	Early Breast Cancer Cancro da Mama Precoce Gabriela Sousa; Manuel Teixeira; Ida Negreiros; João Conde
11:45h	Genomic test, still important in premenopausal women to decide chemo? \| Sónia Oliveira Teste genómico, ainda importante em mulheres pré-menopausa para decidir a quimioterapia?
12:05h	Anthraciclines – old fashion chemotherapy? \| Martine Piccart Antraciclinas – quimioterapia antiga?
12:25h	HER2 disease, can we do better? \| Cláudia Vieira Doença HER2, podemos fazer melhor?
12:45h	Discussion Discussão

13:00h

Lunch / Almoço

14:15h	Conference: Adjuvant Endocrine Therapy: A long and winding road \| Carlos Barrios Conferência: Terapia Endócrina Adjuvante: Um caminho longo e tortuoso
	Chairs: Luís Costa; Ana Ferreira; Joana Belo

15:15h	Immunotherapy Time Tempo da Imunoterapia Miguel Barbosa; Marta Ferreira; Cecília Moura; António Marinho
15:15h	Toxicity and resistance \| Rita Sousa Toxicidade e resistência
15:35h	Immunotherapy in early Breast Cancer – How long? \| Joana M. Ribeiro Imunoterapia no Cancro da Mama precoce – Quanto tempo?
15:55h	New immunotherapy combinations treatments \| Mário Fontes e Sousa Novas combinações de tratamentos de imunoterapia
16:15h	Discussion Discussão

16:30h	ADCs – All new era ADCs – Uma nova era Susana Sousa; Nuno Coimbra; Marta Sousa
16:30h	ADCs development and current use \| Eva Ciruelos Desenvolvimento e uso atual de ADCs
16:50h	HER2 low, new goal? \| Daniela Almeida HER2 low, novo alvo?
17:10h	Discussion Discussão

17:25h	Precision Oncology and Breast Cancer Oncologia de Precisão e Cancro da Mama Rui Henrique; Hugo Nunes
17:25h	Biomarker-driven therapies in Breast Cancer - Experience of IPO Porto Precision Oncology program and Molecular Tumor Board \| Sara Alves Terapias dirigidas por biomarcadores no Cancro da Mama: Experiência do Programa de Oncologia de Precisão do IPO Porto e Molecular Tumor Board
17:45h	Role of Immuno-genomic profiling and translational research in Breast Cancer \| Marie-Sophie Robert Papel do perfil Imuno-genómico e investigação de translação no Cancro da Mama
18:05h	Discussion Discussão

18:20h

Coffee Break

3^rd February 2024 3 de fevereiro 2024

09:00h	Metastatic breast cancer Cancro da mama metastático Carlos Barrios; J.L. Passos Coelho
09:00h	After ICDK 4/6 - Sequential treatments in ER+HER2- \| Miguel Martín Após ICDK 4/6 - Tratamentos sequenciais em doença ER+HER2-
09:20h	HER2 disease advanced Breast Cancer. Selection and sequencing HER2 target therapies \| Alexandra Teixeira Doença HER2 em Cancro da Mama avançado. Seleção e sequencia de terapêutica anti HER2
09:40h	Discussion Discussão

09:55h

Coffee Break

10:25h	BB Disease – Brain & Breast Cancro da Mama e Metástases Cerebrais Cláudia Caeiro; Bruno Carvalho; António Verdelho; Artur Aguiar
10:25h	Oncology questions & answers \| Thomas Bachelot Perguntas & respostas em oncologia
10:45h	Local treatments \| Ana Luísa Vasconcelos Tratamentos locais
11:05h	Discussion Discussão

11:20h	Lifestyle and Breast Cancer – What science says Estilo de vida e Cancro da Mama – O que diz a ciência Paulina Lopes; Joana Sá; Diana Alexandre
11:20h	Exercise, diet and weight \| Inês Leão Exercício, dieta e peso
11:40h	Discussion Discussão

11:55h	Patients and doctors concerns Preocupações de médicos e doentes Mónica Nave; Vanda Patrício; Marina Silva; Susana Almeida
11:55h	Pregnancy \| Ana Sofia Patrão Gravidez
12:10h	Lymphedema and lipedema \| Joana Carvalho Linfedema e lipedema
12:25h	Sexuality \| Mafalda Cruz Sexualidade
12:40h	Rights and duties \| Andreia Andrade Direitos e deveres
12:55h	Discussion Discussão

13:10h

Closing Session
Sessão Encerramento

Programa Científico Provisório

Regras para Submissão de Trabalhos Científicos

Os trabalhos científicos deverão corresponder ao âmbito da temática do Breast Cancer Weekend.

01. Estrutura

Deverá ser utilizado o template word que se encontra no final desta página. Por favor faça download e preencha respeitando a estrutura e exemplos do mesmo:

Título do trabalho;
Nome, apelido, local de trabalho dos autores e email;
Escolha da temática pretendida com a seguinte estrutura:

Séries Clínicas – Introdução, Descrição, Discussão e Conclusão.
Casos Clínicos – Introdução, Descrição, Discussão e Conclusão.
Ciências Básicas – Introdução, Descrição, Discussão e Conclusão.

O conteúdo do resumo não deverá ter a identificação de nenhum dos autores ou fazer alusão a qualquer outro dado que possa comprometer o anonimato. Poderá conter até um máximo de 2500 caracteres, incluídos espaços, respeitando o acordo ortográfico em vigor.

02. Candidatura

Os resumos dos trabalhos científicos deverão ser enviados até ao dia 26 de janeiro 2024 em formato PDF para: eventos@lab52.pt.
Serão notificados todos os autores até ao dia 30 de janeiro 2024 sobre a aceitação do trabalho.
Pelo menos um dos autores terá que estar inscrito no congresso.

03. Formato

Todos os trabalhos aceites serão apresentados em forma de e-poster.
Será disponibilizado template Powerpoint para a sua realização. Este template já se encontrará dimensionado corretamente para o bom funcionamento e visualização. A organização não se responsabiliza pelo não funcionamento ou falta de qualidade dos e-posters elaborados noutros programas ou formatos.
Os trabalhos serão exibidos num ecrã no dia do evento. Deverão ser enviados em formato JPG até ao dia 1 de fevereiro 2024 para eventos@lab52.pt.

04. Prémios

Serão atribuídos o 1º e 2º prémio aos melhores trabalhos científicos de cada área temática. A divulgação dos vencedores será feita na sessão de encerramento no dia 3 fevereiro 2024. Pelo menos um dos autores deverá estar presente na sessão sob pena de não receber o prémio atribuído.

Trabalhos	1º Prémio	2º Prémio
Séries Clínicas	750,00 €	500,00 €
Casos Clínicos	500,00 €	300,00 €
Ciências Básicas	500,00 €	300,00 €

Abstract Template

Organização

Apoio

Patrocinadores

IPO Porto

Instituto Português de Oncologia do Porto FG, EPE

O IPO-Porto tem como missão a prestação de cuidados de saúde, em tempo útil, centrados no doente, não descurando a prevenção, a investigação, a formação e o ensino no domínio da oncologia com o objetivo de garantir elevados níveis de qualidade, humanismo e eficiência.

R. Dr. António Bernardino de Almeida 865,
4200-072 Porto, Portugal

(+351) 225 084 000

www.ipoporto.pt

Ligia Silva

(+351) 914 592 380

Email

eventos@lab52.pt

Email

geral@lab52.pt

Inscrições Encerradas!

Obrigado

19 Dezembro, 2023

Love0

Oporto Mayo Clinic

By admin1990Terminado

Mayo Clinic Update

The Nephrology Department of the Portuguese Institute of Oncology of Porto (IPO-Porto) will organize jointly with the Nephrology Department of the Mayo Clinic, Rochester, USA, a scientific meeting called Mayo Clinic Update, Oporto 2024, 14^th and 15^th June, as part of the celebrations of IPO-Porto’s 50th anniversary. This event will take place in the Auditorium of the Super Bock Arena Complex – Pavilhão Rosa Mota.

Member*LATE REGISTRATION
From June 1^st to June 7^th

€ 100,00

Includes:

Access to Lectures
Documentation Folder
Lunch
Coffee Break
Certificate of Attendance

Non MemberLATE REGISTRATION
From June 1^st to June 7^th

€ 200,00

Includes:

Access to Lectures
Documentation Folder
Lunch
Coffee Break
Certificate of Attendance

* must be a member to one of the following societies
Sociedade Portuguesa de Nefrologia
Sociedad Española de Nefrologia
Sociedade Brasileira de Nefrologia
Sociedade Portuguesa de Medicina Interna

After June 7^th, only registrations made on the local conference will be accepted.

500,00 €

for member & non member

Attendance limited to auditorium capacity

PROGRAM & SPEAKERS

Friday — 14^th June 2024